Cargando…

Cell-Autonomous Role of EGFR in Spontaneous Duodenal Tumors in LRIG1 Null Mice

Detalles Bibliográficos
Autores principales:	Niitsu, H., Lu, Y., Huh, W.J., Love, A.M., Franklin, J.L., Coffey, R.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413138/ https://www.ncbi.nlm.nih.gov/pubmed/33989815 http://dx.doi.org/10.1016/j.jcmgh.2021.05.004

Ejemplares similares

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

LRIG and cancer prognosis
por: Lindquist, David, et al.
Publicado: (2014)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas
por: Chinyengetere, Fadzai, et al.
Publicado: (2015)

Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity
por: Chang, Lei, et al.
Publicado: (2013)

Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway
por: Yang, Hong-Kuan, et al.
Publicado: (2017)

LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance
por: Billing, Ola, et al.
Publicado: (2021)

Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer
por: Ljuslinder, Ingrid, et al.
Publicado: (2009)

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
por: Wang, Y, et al.
Publicado: (2013)

IL-17R–EGFR axis links wound healing to tumorigenesis in Lrig1(+) stem cells
por: Chen, Xing, et al.
Publicado: (2019)

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
por: Rondahl, Veronica, et al.
Publicado: (2013)

Neonatal Duodenal Duplication Cyst
por: AM, Haidar, et al.
Publicado: (2014)

LRIG1 expression and colorectal cancer prognosis
por: Bakherad, Maryam, et al.
Publicado: (2021)

The Prognostic Role of LRIG Proteins in Endometrial Cancer
por: Razumova, Zoia, et al.
Publicado: (2021)

Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice
por: Avellino, Roberto, et al.
Publicado: (2022)

Rlip depletion prevents spontaneous neoplasia in TP53 null mice
por: Awasthi, Sanjay, et al.
Publicado: (2018)

Lrig1 Expression in Human Sebaceous Gland Tumors
por: Pünchera, Jöri, et al.
Publicado: (2016)

Spontaneous Skin Ulceration and Defective T Cell Function in CD18 Null Mice
por: Scharffetter-Kochanek, Karin, et al.
Publicado: (1998)

Vertebrate Lrig3-ErbB Interactions Occur In Vitro but Are Unlikely to Play a Role in Lrig3-Dependent Inner Ear Morphogenesis
por: Abraira, Victoria E., et al.
Publicado: (2010)

Development of Pluoronic nanoparticles of fluorocoxib A for endoscopic fluorescence imaging of colonic adenomas
por: Uddin, Md. Jashim, et al.
Publicado: (2023)

Spontaneous Recovery after Perforation of Duodenal Ulcer
por: Struthers, J. W.
Publicado: (1914)

USP8 modulates ubiquitination of LRIG1 for Met degradation
por: Oh, Young Mi, et al.
Publicado: (2014)

Lrig1 is a positive prognostic marker in hepatocellular carcinoma
por: Yang, Bo, et al.
Publicado: (2016)

LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma
por: Li, Zhi-Qiang, et al.
Publicado: (2022)

A SINE-VNTR-Alu in the LRIG2 Promoter Is Associated with Gene Expression at the Locus
por: Hall, Ashley, et al.
Publicado: (2020)

Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder
por: Roberts, Neil A., et al.
Publicado: (2019)

LRIG2 expression and prognosis in non-small cell lung cancer
por: WANG, GUANGCHUAN, et al.
Publicado: (2014)

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
por: Mao, Feng, et al.
Publicado: (2018)

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer
por: Lindquist, David, et al.
Publicado: (2018)

Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma
por: Ranhem, Cecilia, et al.
Publicado: (2017)

The transmembrane protein LRIG2 increases tumor progression in skin carcinogenesis
por: Hoesl, Christine, et al.
Publicado: (2019)

Neurogenic Defects Occur in LRIG2-Associated Urinary Bladder Disease
por: Grenier, Celine, et al.
Publicado: (2023)

Delayed Retraction of Filopodia in Gelsolin Null Mice
por: Lu, Mei, et al.
Publicado: (1997)

A new dynamic null model for phylogenetic community structure
por: Pigot, Alex L, et al.
Publicado: (2015)

Understanding the null hypothesis (H(0)) in non-inferiority trials
por: Mallat, Jihad
Publicado: (2017)

Soluble LRIG2 Ectodomain Is Released from Glioblastoma Cells and Promotes the Proliferation and Inhibits the Apoptosis of Glioblastoma Cells In Vitro and In Vivo in a Similar Manner to the Full-Length LRIG2
por: Xiao, Qungen, et al.
Publicado: (2014)

Spontaneous choledochoduodenal fistula with tuberculous duodenal ulceration
por: Karthikeyan, VS, et al.
Publicado: (2014)

Oncogenic signaling in amphiregulin and EGFR‐expressing PTEN‐null human breast cancer
por: Kappler, Christiana S., et al.
Publicado: (2014)

In Vivo Analysis of Lrig Genes Reveals Redundant and Independent Functions in the Inner Ear
por: del Rio, Tony, et al.
Publicado: (2013)

Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus
por: Kim, Ji Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t5bgp6vge4t82hlvhdgs6b47i8